Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of YP05002 in Healthy Participants
Sponsor: Yaopharma Co., Ltd.
Summary
This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, efficacy, food effect of YP05002 Tablets in healthy participants
Official title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of YP05002 in Healthy Participants
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
76
Start Date
2025-08-19
Completion Date
2026-06-30
Last Updated
2025-08-06
Healthy Volunteers
Yes
Conditions
Interventions
YP05002
Tablet, QD
Placebo
Tablet, QD
Locations (1)
Nucleus Network Melbourne Clinic
Melbourne, Victoria, Australia